Bouke de Jong

Head, Mycobacteriology Unit

Instituut voor Tropische Geneeskunde

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bouke de Jong is the Head of the Mycobacteriology Unit at the Instituut voor Tropische Geneeskunde in Belgium. His research focuses on mycobacterial diseases, particularly the mechanisms of drug resistance in Mycobacterium tuberculosis and the efficacy of treatment strategies. Recent publications include studies on the impact of antibiotic exposure on resistance development, and innovative treatment approaches for leprosy and tuberculosis in various settings.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Wim Mulders

Institute of Tropical Medicine Antwerp

BELGIUM

View details

Mahboobeh Behruznia

University of Birmingham

UNITED KINGDOM

View details

Maya Ronse

Institute of Tropical Medicine Antwerp

BELGIUM

View details

Matthias Merker

Assistant Professor

Research Center Borstel - Leibniz Lung Center

GERMANY

View details

Claudio Köser

University of Cambridge

UNITED KINGDOM

View details

Conor Meehan

Associate Professor of Microbial Bioinformatics

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bouke de Jong

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis

A Telacebec-Shaped Puzzle Piece in the Treatment of Mycobacterial Diseases

Refined understanding of the impact of the <i>Mycobacterium tuberculosis</i> complex diversity on the intrinsic susceptibility to pretomanid.

Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands

The use of Kudoh method for culture of Mycobacterium tuberculosis and Mycobacterium africanum in The Gambia

Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh

Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea.

Ticks are unlikely to play a role in leprosy transmission in the Comoros (East Africa) as they do not harbour <i>M. leprae</i> DNA.

Face mask sampling (FMS) for tuberculosis shows lower diagnostic sensitivity than sputum sampling in Guinea.

High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin

Collaborators (6)

Wim Mulders

Mahboobeh Behruznia

Maya Ronse

Matthias Merker

Claudio Köser

Conor Meehan

Make your next move.